-
Collaboration And Machine Learning Key For 23andMe’s Drug Discovery Efforts
Jan 31, 2019, 09:45 AM by Michael CroftFull storyBio-IT World | 23andMe is at the forefront of a collaborative effort to forge partnerships with pharma companies and research institutes to improve drug discovery, as well as use resources to capitalize on the growth of personalized medicine.
-
TrialScope and Vivli Partner to Address Rapidly Growing Transparency Needs of Clinical Trial Sponsors and Researchers
Jan 30, 2019, 13:05 PM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Jan 29, 2019 - TrialScope, the global leader in clinical trial transparency, compliance and patient engagement solutions, today announced a strategic partnership with Vivli, a nonprofit organization focused on sharing of clinical trial data through its innovative platformFull story -
Copyright Clearance Center, PAREXEL, Eaton, And More: News From January 2019
Jan 30, 2019, 11:40 AM by Michael CroftFull storyBio-IT World | January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Copyright Clearance Center, PAREXEL, Eaton, and more.
-
WCG Acquires First Clinical Research, LLC
Jan 30, 2019, 08:30 AM by Michael CroftPRINCETON, NJ - Jan 30, 2019 - The WIRB-Copernicus Group®s (WCG) Market Intelligence & Insights Division has acquired First Clinical Research LLC, organizer of the MAGI (Model Agreements & Guidelines International) Clinical Research Conference, which unifies the clinical research ecosystem by facilitating communication and the sharing of best practices among membersFull story -
Certara Launches Version 18 of its Physiologically-based Pharmacokinetic (PBPK) Simcyp Simulator
Jan 29, 2019, 08:26 AM by Michael CroftPRINCETON, NJ - Jan 29, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 18 of its Simcyp® Population-based SimulatorFull story -
Optibrium strengthens senior management team with Financial Director appointment
Jan 28, 2019, 11:28 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Jan 28, 2019 - Optibrium, a developer of software for drug discovery, today announced the appointment of Clare Devlin as Financial DirectorFull story -
Creative BioMart Has Newly Launched Its Stable Cell Line Services
Jan 25, 2019, 22:52 PM by Michael CroftSHIRLEY, NY, 美国 - Jan 26, 2019 - Creative BioMart, a leading provider of high-quality, comprehensive protein products and custom protein manufacturing services for over a decade, has newly launched its stable cell line services for researchers and scientists in need of protein production and assay developmentFull story -
After “CRISPR Babies,” Medical Leaders To Tighten Genome Editing Rules
Jan 24, 2019, 15:00 PM by Michael CroftFull storySTAT | Less than two years after the U.S. National Academy of Medicine produced an exhaustive report on human genome editing, it is planning an international commission on the most controversial use of that technology — creating “CRISPR babies.”
-
Quake Lab Utilizes RNA Sequencing Tool For Food Allergy Diagnostics
Jan 24, 2019, 14:30 PM by Michael CroftFull storyBio-IT World | Researchers in the Stanford lab of Stephen Quake are using single cell RNA sequencing in an effort to provide insight into food allergies and the antibodies that cause them.
-
1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution
Jan 24, 2019, 12:01 PM by Michael CroftST. LOUIS, MO, UNITED STATES - Jan 24, 2019 - 1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop System for use within Partek® Flow® bioinformatics softwareFull story -
Wasdell Group granted HPRA licence at new EU headquarters
Jan 24, 2019, 07:09 AM by Michael Croft- Jan 24, 2019 - The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical and clinical trials industries, has been granted its Health Products Regulatory Authority (HPRA) licence for its new EU headquarters in Dundalk, IrelandFull story -
LG Technology Ventures Makes Strategic Investment in Lygos
Jan 23, 2019, 11:32 AM by Michael CroftBERKELEY, CA, UNITED STATES - Jan 23, 2019 -Full story
Lygos, Inc., a biotechnology-based producer of specialty chemicals that deliver high-value performance without environmental toxicity, today announced that LG Technology Ventures, an investment arm of the South Korean conglomerate LG Group, has made a $5 million investment in its oversubscribed Series B financing round -
IDDI starts Collaborative Research on Ground-Breaking Statistical Method for individualization of Therapy
Jan 23, 2019, 09:09 AM by Michael Croft, BELGIUM - Jan 23, 2019 - The treatment of patients in clinical practice relies on the results of randomized clinical trials. The statistical methods currently used to test the treatment effects in such trials take into account a single criterion called "primary endpoint"Full story -
ChargePoint Technology expands smart monitoring technology into North America
Jan 23, 2019, 04:47 AM by Michael Croft, N/A, UNITED KINGDOM - Jan 23, 2019 - Powder containment and sterile transfer solutions provider, ChargePoint Technology has achieved HazLoc (Hazardous Area) certification for VERIFI to further support customers in North America The HazLoc certification has been granted by the Canadian Standards Association (CSA) and will enable ChargePoint to expand its VERIFI smart monitoring hub into the North American marketFull story -
Creative Biolabs Completed Its Product List of Agonistic Antibody for Research Use
Jan 23, 2019, 00:55 AM by Michael CroftSHIRLEY, NY - Jan 23, 2019 - January 23, 2019, as one of the world-leading suppliers and manufacturers in the field of antibody production, Creative Biolabs recently updated and completed its product list of agonistic antibody in order to assist therapy-related and antibody-based researchesFull story -
Scilligence Joins Accenture’s Life Sciences Research Platform Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research
Jan 22, 2019, 15:47 PM by Michael CroftBOSTON, MA, UNITED STATES - Jan 22, 2019 - Scilligence, a provider of mobile cheminformatics and bioinformatics for the life sciences industry, has joined the Accenture research platform open partner ecosystem, which will allow for the integration of Scilligences informatics solutionsFull story -
PHARMASEAL Launches Engility CTMS, an Innovative Clinical Trial Management Platform for Unified Governance
Jan 22, 2019, 09:34 AM by Michael CroftNOTTINGHAM, UK - Jan 22, 2019 - PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, has launched EngilityÔ CTMS, the first product to be released from its Engility B2B platformFull story -
Sharp completes relocation to $23 million clinical services facility in Bethlehem
Jan 22, 2019, 08:18 AM by Michael CroftBETHLEHEM, PA, UNITED KINGDOM - Jan 22, 2019 - Sharp - a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed its relocation to its $23m state-of-the-art facility in Bethlehem, PAFull story -
Artificial Intelligence In Health Care IT – The Potential And The Watch-Outs
Jan 22, 2019, 07:05 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Few topics have captured the imagination of the general public and executives in the healthcare IT world like Artificial Intelligence. It is important to look beyond the Sci-Fi of AI and instead look at Artificial Intelligence from a purely computer science perspective.
-
Hypha Discovery launches new PolyCYPs® kits to support drug development and candidate optimisation
Jan 22, 2019, 05:14 AM by Michael CroftSLOUGH, UK - Jan 22, 2019 - Hypha Discovery Limited, a leading microbial biotechnology company specialising in biocatalytic solutions for pharmaceutical and agricultural R&D companies, has launched its new line of PolyCYPs® kitsFull story